Pathophysiological roles for IL-18 in inflammatory arthritis.

Area of Science:

• Immunology
• Rheumatology
• Cytokine Biology

Background:

• Interleukin-18 (IL-18) is a cytokine with diverse biological functions.
• IL-18's ability to induce interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) is implicated in inflammatory diseases.
• Elevated IL-18 levels correlate with disease activity in rheumatoid arthritis (RA) and osteoarthritis (OA).

Purpose of the Study:

• To review the role of IL-18 in the pathogenesis of inflammatory arthritis.
• To explore the relationship between IL-18 and TNF-alpha in RA development.
• To discuss the therapeutic potential of targeting IL-18 for RA and OA.

Main Methods:

• Literature review of studies on IL-18 and inflammatory arthritis.
• Analysis of the correlation between IL-18 levels and disease activity in RA and OA.
• Examination of the IL-18 and TNF-alpha feedback loop in RA pathogenesis.
• Review of preclinical data, including IL-18-deficient mouse models of arthritis.

Main Results:

• IL-18 is released by synovial cells in RA and chondrocytes in OA, contributing to joint inflammation and destruction via TNF-alpha induction.
• A positive feedback loop exists between IL-18 and TNF-alpha in RA.
• TNF-alpha inhibitors used in RA treatment reduce circulating IL-18 levels.
• Mice lacking IL-18 are protected from collagen-induced arthritis, a model for RA.

Conclusions:

• IL-18 plays a significant role in the inflammatory and destructive processes of arthritis.
• The interplay between IL-18 and TNF-alpha is crucial for RA development.
• Targeting IL-18 presents a promising therapeutic strategy for managing RA and OA.